Case on Pituitary Macroadenoma

  • Vedha pal S Jeyamani Jaya College of Paramedical Sciences
  • Asha K Rajan Jaya College of Paramedical Sciences
  • Kaviya U Jaya College of Paramedical Sciences
  • Merlin Joan Jaya College of Paramedical Sciences
  • Lavanya R Jaya College of Paramedical Sciences
Keywords: Artemether, Chemotherapy, Dihydroartemisnin, Macroadenoma, Pituitary

Abstract

Pituitary adenomas are slowly progressive and usually benign type of tumors which may induce a poor quality of life of patients due to progressive loss of vision over time by compression of optic nerves, cavernous sinus, optic chiasm. Its therapy generally involves differential diagnosis with an MRI of Brain and surgical option with radiation therapy. Here with we present a case of 48 year old women who had undergone microscopic transnasal transphenorbital excision of tumor two years ago of pituitary macroadenoma. She was not on any chemotherapy which led to a recurrence of her tumor. Presently her MRI scan and histopathologic reports confirms the diagnosis of Pituitary macroadenoma which was effectively treated surgically and put up on Dihydroartemisnin, a derivative of Artemether which has similar cytotoxic properties as that of artemether.

Author Biographies

Vedha pal S Jeyamani, Jaya College of Paramedical Sciences

Department of Pharmacy Practice,
Jaya College of Paramedical Sciences,
College of Pharmacy, Thiruninravur,
Chennai, Tamil Nadu, India

Asha K Rajan, Jaya College of Paramedical Sciences

Department of Pharmacy Practice,
Jaya College of Paramedical Sciences,
College of Pharmacy, Thiruninravur,
Chennai, Tamil Nadu, India

Kaviya U, Jaya College of Paramedical Sciences

Department of Pharmacy Practice,
Jaya College of Paramedical Sciences,
College of Pharmacy, Thiruninravur,
Chennai, Tamil Nadu, India

Merlin Joan, Jaya College of Paramedical Sciences

Department of Pharmacy Practice,
Jaya College of Paramedical Sciences,
College of Pharmacy, Thiruninravur,
Chennai, Tamil Nadu, India

Lavanya R, Jaya College of Paramedical Sciences

Department of Pharmacy Practice,
Jaya College of Paramedical Sciences,
College of Pharmacy, Thiruninravur,
Chennai, Tamil Nadu, India

References

Chen X., Dai J., Ai L, Ru X., et al (2011); Clival invasion on multi-detector CT in 390 pituitary macroadenomas: Correlation with sex, subtype and rates of operative complication and recurrence; AJNR;32(4); 785-9.

Choudhary V & Bano S (2011); Imaging of the pituitary: Recent advances; Indian J Endocrinol Metab; 15(3); 216-23.

Dekkers OM., Pereira AM., Roelfsema F., et al (2006), Observation alone after transsphenoidal surgery for non-functioning pituitary macroadenoma; J Clin Endocrinol Metab; 91(5); 1796-1801.

Inderjit IK., Chidambarathan N., Sundar K, Ahmad I (2001); Value of dynamic MRI imaging in pituitary adenomas; Indian J Radiol Imaging;11(4); 185-190.

Johnson MD., Woodburn CJ., Vance ML (2003); Quality of life in patients with a pituitary adenoma; Pituitary; 6(2); 81-87.

Lai H & Singh NP (1995); Selective cancer cell cytotoxicity from expo-sure to dihydroartemisinin and holotransferrin; Cancer Letter; 91(1); 41-46.

Park P., Chandler WF., Barkan AL., et al (2004); The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas; Neurosurg; 55(1); 100-106.

Sassolas G., Trouillas J., Treluyer C., Perrin G (1993); Management of nonfunctioning pituitary adenomas; Acta Endocrinol; 129 Suppl 1; 21-6

Senovilla L., Nunez L., de Campos JM., et al (2004); Multifunctional cells in human pituitary adenomas: implications for paradox-ical secretion and tumorigenesis; J Clin Endocrinol Metab; 89(9); 4545-4552.

Yildiz F., Zorlu F., Erbas F., Atahan L (1999); Radiotherapy in the man-agement of giant pituitary adenomas; Radiother Oncol; 52(3); 233-237.

Zhang F., Gosser DK Jr., Meshnick SR (1992); Hemin-catalyzed decom-position of artemisinin (qinghaosu); Biochem Pharmacol; 43(8); 1805-1809.

Published
2019-03-01
How to Cite
[1]
Jeyamani, V. pal, Rajan, A., U, K., Joan, M. and R, L. 2019. Case on Pituitary Macroadenoma. PharmaTutor. 7, 3 (Mar. 2019), 26-30. DOI:https://doi.org/10.29161/PT.v7.i3.2019.26.
Section
Articles